Open Access

Multicopy plasmid integration in Komagataella phaffii mediated by a defective auxotrophic marker

  • Maritza Ocampo Betancur1,
  • Viviane Castelo Branco Reis1,
  • André Moraes Nicola2,
  • Janice Lisboa De Marco1,
  • Lídia Maria Pepe de Moraes1 and
  • Fernando Araripe Gonçalves Torres1Email author
Microbial Cell Factories201716:99

DOI: 10.1186/s12934-017-0715-8

Received: 17 April 2017

Accepted: 2 June 2017

Published: 8 June 2017



A commonly used approach to improve recombinant protein production is to increase the levels of expression by providing extra-copies of a heterologous gene. In Komagataella phaffii (Pichia pastoris) this is usually accomplished by transforming cells with an expression vector carrying a drug-resistance marker following a screening for multicopy clones on plates with increasingly higher concentrations of an antibiotic. Alternatively, defective auxotrophic markers can be used for the same purpose. These markers are generally transcriptionally impaired genes lacking most of the promoter region. Among the defective markers commonly used in Saccharomyces cerevisiae is leu2-d, an allele of LEU2 which is involved in leucine metabolism. Cells transformed with this marker can recover prototrophy when they carry multiple copies of leu2-d in order to compensate the poor transcription from this defective allele.


A K. phaffii strain auxotrophic for leucine (M12) was constructed by disrupting endogenous LEU2. The resulting strain was successfully transformed with a vector carrying leu2-d and an EGFP (enhanced green fluorescent protein) reporter gene. Vector copy numbers were determined from selected clones which grew to different colony sizes on transformation plates. A direct correlation was observed between colony size, number of integrated vectors and EGFP production. By using this approach we were able to isolate genetically stable clones bearing as many as 20 integrated copies of the vector and with no significant effects on cell growth.


In this work we have successfully developed a genetic system based on a defective auxotrophic which can be applied to improve heterologous protein production in K. phaffii. The system comprises a K. phaffii leu2 strain and an expression vector carrying the defective leu2-d marker which allowed the isolation of multicopy clones after a single transformation step. Because a linear correlation was observed between copy number and heterologous protein production, this system may provide a simple approach to improve recombinant protein productivity in K. phaffii.


Komagataella phaffii Leucine biosynthesis Auxotrophic marker Multicopy integration Expression system


The methylotrophic yeast Komagataella phaffii (formerly Pichia pastoris) is one of the most important expression platforms for the production of recombinant proteins [1, 2]. It offers many advantages such as: easy genetic manipulation; growth at high cell densities, e.g. 200 g L−1 dry weight during a glucose-limited fed-batch cultivation [3]; ability to produce heterologous proteins at high levels, e.g. more than 18 g L−1 of lignocellulolytic enzyme TrCBH2 [4]; and post-translational modifications similar to higher eukaryotes [5].

Due to its biotechnological interest, many studies have focused on the genetic improvement of K. phaffii in order to optimize protein production. A well-established approach to accomplish this is to assure high transcription levels of a heterologous gene thus favoring the translation of the desired mRNA. Typically, this can be achieved by constructing expression cassettes under the control of strong promoters or/and by screening clones bearing multiple copies of the desired gene (for a review see [6, 7]). Genetic strategies are available for the isolation of multicopy clones. Yeast cells can be transformed with vectors carrying extra copies of the expression cassette cloned in tandem (multimeric construction) [8] or successive rounds of transformation can be performed using different selection markers [9]. In both cases cloning is labor-intensive and the extent of copy number increase is limited [10].

Another option consists in the use of antibiotic-resistance markers, in which case one looks for transformants growing in higher concentrations of the antibiotic (direct selection method) [11]. A previous study showed that this type of selection resulted in the isolation of sporadic multicopy integrants with increased productivity of the desired protein [12]. Dominant markers can also give rise to multicopy clones by posttransformational vector amplification (PTVA) [13] or liquid PTVA [14]. It has been demonstrated that after transformation with a few copies of a vector carrying a drug-resistance marker, such as zeocin or G418, cells can be selected in stepwise higher concentrations of the drug resulting in the selection of multicopy clones. The use of PTVA in combination with the use of rDNA non-transcribed sequence (NTS) as an integration target sequence resulted in multicopy clones in K. phaffii [15]. Besides being a laborious and expensive method due to the high costs of eukaryotic antibiotics, one disadvantage of the use of dominant markers is that a significant number of clones show increased natural drug-resistance for other reasons than vector copy number.

An alternative strategy is based in the use of defective auxotrophic markers, i.e. genes that are poorly transcribed typically due to extensive deletions of their promoters. To compensate the low transcription levels, cells need to amplify the copy number of the defective marker in order to recover prototrophy. Consequently, copy number of the neighboring heterologous gene is also amplified [16]. An example of such defective marker is the leu2-d allele which contains only 29 base pairs of the original promoter and is commonly used in S. cerevisiae for plasmid maintenance at high copy number under selective pressure [17]. Due to this feature, this system has also been used to increase recombinant protein production in this yeast [1820]. This prompted us to develop an analogous system to be employed in K. phaffii. To accomplish this, we sought the construction of a K. phaffii strain auxotrophic for leucine and the development of an integrative expression vector based on leu2-d as a tool to increase recombinant protein production in this yeast.

Results and discussion

Construction of a leu2 auxotrophic strain

Genetic manipulation of K. phaffii is possible due to its widely used transformation system which enables integration of foreign DNA into the genome via homologous recombination [21]. This approach has been successfully used to disrupt several genes in order to create auxotrophic mutants, e.g. URA5 [22], ARG1, ARG2, ARG3, HIS1, HIS2, HIS5 and HIS6 [23]. Recently, a CRISPR-Cas9 system was developed for K. phaffii which has greatly facilitated gene knock out in this yeast [24].

We sought the development of a leucine auxotrophic strain by gene knock out of the endogenous K. phaffii LEU2 gene with a leu2::kan disruption cassette. The resulting strain (LK) was then transformed with a plasmid expressing CreA recombinase for marker removal thus generating strain M12 (see Additional file 1 for details). Growth analysis on plates containing G418 or hygromycin B confirmed the loss of all dominant markers (Fig. 1a). The phenotypic behavior of the strains obtained with respect to leucine assimilation was then analyzed. As expected, LK and M12 strains were not able to grow on MD lacking leucine (Fig. 1b). We expected that supplementation of MD medium with leucine would allow both leu2 strains to recover prototrophy, however, even with an oversuplemmentation (0.08%) of leucine cells were unable to grow (Fig. 1b). We reasoned that ammonium sulphate present in MD medium could be affecting leucine uptake because when this salt was replaced by 0.04% leucine as sole nitrogen source both leu2 strains grew as well as wild-type X-33 (Fig. 1c). This result is in accordance with a previous work [25] which showed that cells grown in minimal medium exhibited an increase in the rate of leucine uptake when this amino acid was the sole nitrogen source. It is known that the addition of NH4 + to yeast cells causes nitrogen catabolite inactivation and repression of several enzymes and permeases involved in the utilization of secondary nitrogen sources [26]. Leucine has been shown to be transported by at least three systems in S. cerevisiae: GAP (general amino acid permease), S1 (high-affinity permease) and S2 (low-affinity permease) [27]. In NH4 +-containing media the activity of GAP is inhibited [28, 29] and the activity of S1 and S2 proteins is strongly reduced [30]. In addition, two redundant low affinity leucine permeases coded by the AGP2 and AGP3 genes are overexpressed when other permeases are inhibited [31]. The observation that prototrophy could only be achieved in high leucine concentrations can be explained by the fact that, in the presence of NH4 +, leucine uptake is mainly due to low-affinity permeases. The effects of NH4 + on leucine permeases could be related to intracellular pH as it has been shown that a S. cerevisiae leu2 strain was more sensitive to internal acidic conditions [32]. In yeast, amino acids and other nutrients are taken up by a proton symport mechanism [33]. When NH4 + (a conjugated weak acid) is internalized by specific transporters it undergoes deprotonation and as a result the proton gradient is dissipated leading to acidification of the cytosol [34]. To test this, MD medium was buffered to pH 6.0 and as a result prototrophy was readily recovered as shown in Fig. 1d.
Fig. 1

Strain phenotypic analysis. Strains LK and M12 were grown in different media to confirm drug resistance and leucine assimilation. X-33 was used as a control. a YPD containing G418 or hygromycin B (Hyg B). b MD lacking or not leucine in different concentrations. c MD with leucine replacing ammonium sulfate. d Buffered MD (pH 6.0) containing leucine. X-33 wild-type strain with intact LEU2 gene, LK leu2 strain disrupted with kan cassette, M12 strain obtained after marker removal with CreA recombinase

Heterologous expression in K. phaffii M12

In order to test K. phaffii M12 for heterologous expression we constructed an integrative vector, pGFP-L2, containing LEU2 as selectable marker and the enhanced GFP (EGFP) reporter gene under the control of the methanol-inducible P AOX1 promoter. After electroporation of K. phaffii M12 with linearized pGFP-L2, one colony was randomly chosen and grown under non-inducible (glycerol) and inducible (methanol) conditions to test for intracellular production of the EGFP. Figure 2 shows the result of fluorescence microscopy analysis for the presence of EGFP. As expected, no fluorescence was detected under non-inducible conditions and EGFP could only be detected when methanol was added. This result shows that K. phaffii M12 can recover prototrophy upon transformation with a vector carrying a wild-type LEU2 marker. However, since the strategy used for LEU2 disruption in M12 left the promoter region intact, a single copy of a defective version of this gene could potently integrate at this locus by homologous recombination and reestablish prototrophy without the need of other copies of the marker. In order to develop a system based on defective LEU2 for multicopy integration, we decided to use the S. cerevisiae leu2-d allele which has 68% identity with the K. phaffii LEU2 homologue and should reduce the chances of homologous recombination at the disrupted leu2 locus in M12.
Fig. 2

Heterologous expression in K. phaffii M12. Intracellular expression of enhanced green fluorescent protein (EGFP) was visualized by epifluorescence microscopy. Untransformed (M12) and transformed (M12 + GFP) cells were viewed under differential interference contrast (DIC) or fluorescence (FM) microscopy after growth in glycerol or methanol containing media. All images were collected with the same exposure time

Multiple copy integration

Although the defective leu2-d allele has been successfully used to increase plasmid copy number and protein production in S. cerevisiae it has not yet been tested for the same purpose in K. phaffii. In a previous work, attenuated ADE1 and ADE2 genes involved in adenine biosynthesis were used to develop a color-based system for the screening of multicopy integrants in K. phaffii [35]. However, this system is based on large plasmids and, in some cases, the effects of background transcription from vector sequences were responsible for the recovery of adenine prototrophy.

We constructed an expression vector, pKGFP-ld (Fig. 3), carrying the leu2-d defective marker and an EGFP reporter construct under the control of the phosphoglycerate kinase 1 promoter (P PGK1 ). In order to circumvent the possibility of spurious marker expression, leu2-d was cloned in the opposite orientation of the other yeast promoters present on the vector (P PGK1 and P TEF1 ). Furthermore, the presence of the kan marker under the control of dual-promoters allows plasmid selection in Escherichia coli and may be used to confirm multicopy integration by plating transformed cells on media containing increasing concentrations of the antibiotic G418.
Fig. 3

Physical map of pKGFP-ld expression vector for multiple copy integration in K. phaffii. leu2-d defective LEU2 allele from S. cerevisiae. P PGK1 and P TEF1 promoters from the K. phaffii PGK1 and TEF1 genes, respectively, P EM7 synthetic E. coli promoter, kan G418/kanamycin resistance gene, EGFP enhanced green fluorescence gene, CYCtt and AOX1tt transcription termination sequences from CYC1 and AOX1 genes, respectively, ori E. coli origin of replication

Seven days after transformation of K. phaffii M12 cells with pKGFP-ld, colonies of diverse sizes were observed on MD plates. Ten transformants representing colonies with different sizes were selected for further analysis. After a few passages on fresh MD plates four clones derived from the smallest colonies present on the original transformation did not grown upon replica plating and were removed from this study. We speculate that these abortive clones were transformed with a limited number of copies of the defective marker, thus they were unable to sustain growth under selective conditions.

A growth kinetic analysis of the six remaining clones was performed on MD medium (Fig. 4). The calculated maximum growth rates (Table 1) showed that larger clones present on the original transformation plate (clones 1, 4, 5 and 6) exhibited a growth profile similar to that of K. phaffii X-33 whereas small sized colonies (clones 2 and 7), as expected, exhibited smaller growth rates. Analysis of variance followed by Tukey’s post-test showed significant difference in maximum growth rates presented in Table 1 for clones 2 and 7 when compared to X-33 (p < 0.05). Similar results were obtained when truncated ADE1 and ADE2 were used as selectable defective markers to transform K. phaffii [35]. In this case, multicopy clones were also identified as colonies with larger sizes. We hypothesized that, in order to compensate the poor transcription from leu2-d, cells would require additional integrated copies of defective marker to recover full prototrophy. This prompted us to determine the copy number of vectors integrated into the K. phaffii genome by Southern blot.
Fig. 4

Growth kinetic of selected clones transformed with pKGFP-ld. Cells were grown on MD medium at 30 °C during 72 h. Growth was expressed as the natural logarithm of OD600 which was measured every 30 min. Initial OD600 = 0.08. X-33 K. phaffii wild-type strain

Table 1

Main features of the selected clones studied in this work


µmax (h−1)

Vector copy number

EGFP production (fluorescence units)


0.1596 ± 0.0062


19215 ± 2388


0.0708 ± 0.0022


7705 ± 550


0.1614 ± 0.0027


23,688 ± 2152


0.1408 ± 0.0075


18,387 ± 1045


0.1650 ± 0.0078


20,074 ± 1738


0.0502 ± 0.0064


6711 ± 206


0.1707 ± 0.0069



µ max maximum growth rate, ND not determined

Because pKGFP-ld was linearized with SacI, a restriction site within P PGK1 (Fig. 3), most events of integration would be primarily targeted to this locus. According to the schematic representation shown in Fig. 5a, if a single copy of the vector had integrated into the PGK1 locus, two fragments of 3.4 and 4.8 kb would be expected. Two or more integrated copies would yield an additional 5.5 kb fragment which would increase in intensity for each additional copy added. The results from the Southern blot analysis are shown in Fig. 5b. As expected, the M12 untransformed strain showed the 2.8 kb fragment, which corresponds to the intact PGK1 locus. All transformed clones showed the 5.5 kb fragment thus confirming the in tandem integration of at least two copies of the vector. The observation that clone 5 showed other bands (including the 2.8 kb fragment) which were not present in the other clones suggests that, in this particular clone, the vector had integrated in a different manner. This is not entirely unexpected since it has recently been shown that a transforming cassette can integrate into the K. phaffii genome in different cassette-to-cassette orientations and secondary recombination events may also occur [36]. Also, we cannot exclude the possibility of off-target integration events mediated by non-homologous end joining (NHEJ) which is the main repair system in filamentous fungi and higher eukaryotes [37]. Table 1 shows that that faster growing clones 1, 4, 5 and 6 showed the highest vector copy number (≥14 copies) as compared to slower growing clones 2 and 7 which had no more than 7 copies. Growth rate and copy number showed a linear correlation (R2 = 0.8748) (Fig. 5c). These results are in agreement with the prediction that faster growing clones would have more integrated copies of the defective marker.
Fig. 5

Vector copy number determination. a Schematic representation of genomic contexts and expected sizes of bands obtained after hybridization with a PGK probe (annealing positions are represented by a red line). Dark grey areas correspond to integrated P PGK1 sequences derived from vector. b Result of Southern blot analysis. c Correlation between copy number and maximum growth rates of selected clones. Error bars represent standard error of the mean. M O’GeneRuler 1 kb DNA ladder, M12 K. phaffii leu2 strain, E EcoRI restriction site

Genetic stability

Previous works have shown that single or low copy integrated messages are genetically stable in K. phaffii under different conditions [38, 39], however, few studies have focused on the integrity of multicopy clones. Since multicopy K. phaffii strains generally arise from multiple events of homologous recombination at the same locus, the integrated messages are typically repeated in tandem. The stability of such array may be compromised by excisional recombination which can “loop out” the genetic message under non-selective conditions [14], [40]. In order to test the stability of integrated pKGFP-ld, transformed cells were grown in non-selective medium (YPD) for 36 and 72 generations. The culture was transferred to fresh medium every 24 h to ensure that cells were in exponential phase throughout the experiment. After growth for 96 h or 144 h (36 and 72 generations, respectively), copy number of the selected clones was assessed by Southern blot analysis which showed that all clones maintained the original vector copy number (data not shown).

In a recent work, S. cerevisiae strains with multiple integrated cassettes bearing different defective auxotrophic markers also showed mitotic stability under prolonged nonselective conditions [41]. S. cerevisiae cells transformed with five or more copies of an integration vector conferring resistance to G418 and expressing SUC2 (invertase) were very unstable during long-term culture in non-selective medium [42]. Likewise, when K. phaffii was transformed with a set of vectors containing sequentially increasing copies of porcine insulin precursor gene (PIP), both low and high copy strains were stable in serial culture in non-selective YPD medium. However, in high copy strains, loss of PIP cassettes was observed after 96 h of methanol induction [43].

Based on these previous results, it has been proposed that multicopy strains should be carefully evaluated for genetic stability especially under conditions of high expression or secretion [43]. In our work, since EGFP was produced intracellularly from a moderately strong K. phaffii promoter (P PGK1 ) [44], it is possible that the titers of this particular protein were not high enough to compromised cell growth as shown on Fig. 4, hence, genetic stability was observed.

Correlation between copy number and protein production

In order to determine the correlation between plasmid copy number and increased heterologous protein production, intracellular fluorescence emission of each selected clone was determined by flow cytometry. As shown in Fig. 6a, all selected clones exhibited fluorescence emission higher than the untransformed M12 strain. EGFP production was the highest in clones 1, 4, 5 and 6 which exhibited higher plasmid copy number, whereas moderate production was observed in clones 2 and 7 (Table 1). Analysis of variance followed by Tukey´s post-test showed significant difference in EGFP production in clones 1, 4, 5 and 6 when compared to M12 control strain (p < 0.05). The EGFP fluorescence from clones 2 and 7 was not high enough to result in statistically significant differences in EGFP production in comparison to M12 (p > 0.05). However, it is important to notice that the percentage of M12 cells producing EGFP (cells positive for EGFP) was less than 1%. As shown in Fig. 6b, we observed a linear correlation between vector copy number and EGFP production as measured by flow cytometry (R2 = 0.8757). It is expected that at a certain copy number the production of the heterologous protein might become detrimental to the cell; however, for the examined clones, we did not observe a decrease in cell viability nor in EGFP production which augmented linearly with up to 20 integrated copies. Similarly, an increase of up to eight copies of the hepatitis B surface antigen (HBsAg) gene showed a linear correlation with the concentration of mRNA and translated protein in K. phaffii [45].
Fig. 6

Intracellular EGFP production. a Flow cytometry analysis of the cells positive for EGFP production. b Correlation between copy number and EGFP production. M12 leu2 strain. Error bars represent standard error of the mean. Asterisks indicate significant difference between the evaluated clone and the M12 control strain according to ANOVA followed by Tukey’s post-test (p < 0.05)

However, the relationship between gene copy number and protein production is not always linear and in some cases it proved to be detrimental, especially for secreted proteins [6]. In another study involving EGFP, an increase of the secreted protein was observed with up to three copies but a decrease occurred with six copies [46]. When multicopy clones were used to produce intracellular human superoxide dismutase (hSOD) and secreted human serum albumin (HSA) a difference was observed in the correlation of gene copy number and productivity between non-secreted and secreted proteins [15]. The productivity of hSOD correlated linearly with gene copy number, while HSA productivity increased up to approximately 5–7 gene copies, and then decreased with higher copy numbers. K. phaffii strains secreting human trypsinogen under the control of the AOX1 promoter presented a positive correlation between copy number and product yield from 1 to 2 copies per cell, and a negative correlation at 3 or more copies [47]. Upon overexpression, great part of the heterologous protein was retained in the insoluble fraction of the endoplasmic reticulum. From this studies it is clear that bottlenecks in the secretory pathway are to some extent responsible for the low productivity of some multicopy clones [6].

Since the effect of gene dosage may vary from one protein to another, it is not possible to define the optimal copy number for any specific heterologous gene which should be assessed on a case-by-case basis. However, by using the approach presented in this work one can easily obtain a panel of clones with different copy numbers to be screened for the desired application. Furthermore, we envision that this approach might be also applied in synthetic biology studies in which different doses of specific genes may be required. This could be rapidly achieved by transforming M12 with different plasmids bearing the leu2-d marker following a screening for the desired phenotype. Work is underway in our laboratory to test this new application.


In this work, we proposed a simple approach to obtain K. phaffii clones containing multiple copies of a desired expression vector. Our genetic system is based on a K. phaffii strain auxotrophic for leucine which is transformed with an expression vector bearing a defective leu2-d marker. The main advantage of the approach proposed here is the ease in selecting multicopy clones, in our case this was based on colony size. This approach might serve as a first step in the construction of strains with higher productivity thus lowering the costs of industrial recombinant protein production.


Strains and growth conditions

Komagataella phaffii GS115 (his4) and X-33 (Invitrogen) were used as a source of template DNA to amplify LEU2 and cell host to perform transformation with the disruption cassette, respectively. K. phaffii was routinely grown on YPD (1% yeast extract, 2% peptone and 2% glucose) at 28 °C. Solid medium was prepared by the addition of 2% agar. After transformation yeast cells were plated on YPD containing 300–500 µg mL−1 G418 or 150 µg mL−1 hygromycin B. Transformants were tested on MD [0.34% Yeast Nitrogen Base (YNB), 1% ammonium sulphate, 2% glucose, 0.4 µg mL−1 biotin and 2% agar] and buffered MD [MD with 100 mM potassium phosphate (pH 6.0)] supplemented or not with 0.04 or 0.08% leucine. For induction of heterologous gene expression from the P AOX1 promoter cells were grown in a medium containing 1% yeast extract, 2% peptone, 100 mM potassium phosphate (pH 6.0), 0.34% YNB, 1% ammonium sulphate, 0.4 µg mL−1 biotin supplied with 1% glycerol (BMGY medium) or 0.5% methanol (BMMY medium). When liquid medium was used, growth was carried out under agitation (200 rpm) in shake flasks with a volume at least 10 times greater than the volume of the medium.

Cloning procedures were carried out in E. coli XL10-gold (Stratagene, USA) which was cultivated in modified LB medium (0.5% yeast extract, 1% peptone and 1% NaCl) containing the appropriate antibiotic for selection of transformants (100 µg mL−1 ampicillin or 50 µg mL−1 kanamycin). Bacterial cells were grown at 37 °C with constant shaking (250 rpm). For solid medium, 1.5% agar was added.


Phusion high-fidelity DNA polymerase (Finnzymes) was routinely used for PCR according to the instructions of the manufacturer. To amplify LEU2, Easy Taq DNA polymerase (LGC Bio, Brazil) was used in a final volume of 50 μL consisting of 0.2 mM dNTP, 0.2 μM each primer, 2 mM MgCl2, Easy Taq buffer 1X, 2 U polymerase and 1–5 ng template DNA. PCR involved an initial denaturation step at 96 °C for 3 min followed by 30 cycles of 60 s/94 °C, 1 min/60 °C, 2 min/72 °C and a final elongation step at 72 °C for 5 min.

DNA manipulations

Plasmid extraction, electrophoretic analysis and other basic DNA manipulations were performed as described previously [48]. For DNA elution from agarose gels and for amplicon purification Wizard SV Gel and PCR Clean-Up System (Promega, USA) were used according to the manufacturer’s instructions, respectively. Genomic DNA was purified by using Wizard Genomic DNA Purification Kit (Promega, USA) using the manufacturer’s protocol.

Construction of disruption cassette

First, LEU2 was amplified by PCR from K. phaffii GS115 genome with primers PpLEU2-F1 and PpLEU2-R2 (Table 2) which introduce PvuII restriction sites at their 5´-ends. Primers were designed based on the published sequence of the K. phaffii chromosome 3 (accession # FR839630.1). The amplified 1.7 kb fragment included the LEU2 coding region and ~300 bp of both upstream and downstream sequences. LEU2 was cloned into pGEM-T easy (Promega) resulting in pGEM-LEU. This vector was digested with EcoRV to remove 375 bp of the coding region of LEU2 (positions 405–750). To disrupt LEU2, first, a 1.7 kb fragment containing a kan expression cassette flanked by loxP sites was amplified from pPICKα [49] with primers ZeoBlas-F3 and ZeoBlas-R3 (Table 2). This amplicon was cloned into EcoRV-digested pGEM-LEU generating plasmid pLEUΔkan. Finally, the leu2::kan disruption cassette was released after digestion of pLEUΔkan with PvuII prior to yeast transformation.
Table 2

Primers used in this work


Sequence (5′→3′)*

Restriction site















BamHI and BglII



BamHI and BglII











* Restriction sites are underlined

Marker excision

A vector based on pYRCre was constructed in order to promote marker excision in K. phaffii. Plasmid pYRCre was originally used to express the CreA recombinase in S. cerevisiae [49]. The P GAL1 promoter present in this vector was removed after XbaI digestion and replaced by a 441-bp fragment corresponding to the S. cerevisiae P TEF1 promoter which was obtained by PCR using primers TEF-1F and TEF-1R (Table 2). The amplicon was digested with AvrII and cloned into XbaI-digested pYRCre. The resulting vector, pYRCre2, was used to transform K. phaffii and selection was made on YPD plates containing hygromycin B. Transformants were incubated at 28 °C for 3 days to allow expression of CreA recombinase and then selected clones were transferred to an YPD plate for plasmid curing. Isolated colonies were replica plated on YPD plates containing G418 or hygromycin B to confirm the removal of kan marker and cure of pYRCre2, respectively.

Construction of expression plasmid pGFP-L2

First, a vector constructed in our lab derived from pPIC9 (Invitrogen, USA) with the EGFP reporter gene under the control of the P AOX1 promoter was digested with EcoRV. This digestion removed the entire HIS4 sequence, which was replaced by the LEU2 gene obtained from pGEM-LEU after digestion with PvuII. The resulting vector, pPIC-LEU, was digested with BamHI and NotI to remove the EGFP gene which was fused in-frame to the α-factor secretion signal. This secretable version of EGFP was replaced by a 741 bp EGFP fragment from pEGFP-N3 (Clontech, USA) after digestion of this plasmid with the same enzymes. The resulting plasmid, which allows intracellular expression of EGFP, was named pGFP-L2. Before K. phaffii transformation pGFP-L2 was linearized with SacI to promote targeted integration to the P AOX1 locus.

Construction of expression vector pKGFP-ld

The leu2-d allele was amplified by PCR from S. cerevisiae genome with primers 5- and 3-leud (Table 2). The amplified 1.4 kb fragment included the LEU2 coding region with its transcription termination region and only 29 bp of its promoter [17]. The leu2-d amplicon was cloned into pBlueScript SK II (Agilent Technologies) and then liberated after BglII digestion for subcloning into BamHI-linearized pPICK2 [50] resulting in pK-ld vector. This vector was digested with SacI and NotI to remove the α-factor secretory sequence. This digestion also removed a 179 bp fragment from P PGK1 which was restored when the EGFP gene was cloned. The 916 bp fragment including the EGFP gene fused to the 179 bp fragment from the P PGK1 was obtained by digestion of pPICK-GFP [a vector derived from pPIC9 (Invitrogen) for intracellular expression of EGFP under the control of P PGK1 ] with SacI and NotI. Cloning of this 916 bp fragment into pK-ld resulted in pKGFP-ld vector. This vector was linearized with SacI to target integration to the PGK1 locus.

Yeast transformation

Komagataella phaffii X-33 was transformed by electroporation following the protocol described in the Pichia Expression Kit (Invitrogen). Transformation with pYRCre2 was carried out as previously described for the auto-replicative pPICHOLI vector [51].

Fluorescence microscopy

Komagataella phaffii cells expressing EGFP were grown in 5 mL BMGY for 16 h at 28 °C. After cell count, pelleted cells were re-suspended in 20 mL BMMY to a final OD600 of 0.3. The culture was incubated at 28 °C and methanol was added to a final concentration of 0.5%. After 24 h of induction cells were imaged in a Zeiss Axio Observer Z1 Inverted Fluorescence Microscope equipped with 63× NA 1.4 oil immersion objective and a cooled CCD camera to analyze EGFP fluorescence. The images were acquired with Zen2011 software (Zeiss) and manipulated with Microsoft Office Picture Manager or Adobe Photoshop.

Growth kinetics

A fresh colony was inoculated in 500 µL of MD medium in a deep-well plate and incubated for 24 h at 30 °C and 200 rpm. The appropriate volume of this culture was inoculated in 100 µL of MD to an OD600 = 0.08 in a 96-well plate. Cell growth was performed on the Epoch Microplate Spectrophotometer (Biotek) by incubating at 30 °C under agitation of 300 rpm for 72 h. OD600 data was collected every 30 min. Three biological replicates were tested for each analyzed clone and the mean of the three values was presented. Natural logarithm of OD600 values was used to construct growth curves. Maximal growth rate was calculated from the slope of the linear section of these curves (up to eight hours growth).

Southern blot analysis

Yeast cells were grown in 40 mL of MD medium at 30 °C under agitation during 24 h and the DNA was extracted using phenol–chloroform as previously described [48]. Aproximately 10 µg of genomic DNA were digested with EcoRI at 37 °C overnight. Digested DNA was applied in 0.8% agarose gel and then transferred to nitrocellulose membrane as described [48]. Probe labeling, hybridization and detection were made using the AlkPhos Direct Labeling and CDP-Star Detection System (GE Life Sciences) following especifications of the manufacturer. The probe used was a fragment of ~600 bp corresponding to the PGK1 promoter obtained by digestion of pKGFP-ld with BglII and BamHI. The temperature for hybridization was 55 °C. Chemiluminescence was detected using the Amersham Imager 600 system (GE Life Sciences) and band intensity was measured with the use of the ImageQuant TL 8.1 software.

Genetic stability testing

The stability of the heterologous DNA integrated into the yeast genome was tested in shake flasks after 36 and 72 generations. A fresh colony was grown in 10 mL YPD medium for 24 h at 30 °C and 200 rpm. Then, 400 µL of this pre-inoculum were inoculated in 40 mL YPD and incubated under the same conditions for 24 h. A 400 µL sample of the culture was transferred to a new flask with 40 mL YPD and incubated under the same conditions for 24 h. This procedure was repeated four more times for a total growth time of 144 h. After 96 h (36 generations) and 144 h (72 generations) genomic DNA was extracted and submitted to Southern blot analysis as described above.

Flow cytometry

Yeast cells were grown in 5 mL of MD medium for 24 h at 30 °C and agitation. The required volume of each pre-inoculum was inoculated in 5 mL of MD to start the culture with an OD of 0.5. After 24 h of incubation at 30 °C under agitation cells were washed twice with PBS (137 mM NaCl, 2.7 mM KCl, 10 mM Na2HPO4 and 2 mM KH2PO4, pH 7.4) containing 0.5% Tween by centrifugation at 3000×g for 5 min at 4 °C. Cells were suspended in the required volume of PBS to obtain approximately 106 cells mL−1. Cells were maintained at 4 °C until analysis with FACSVerse flow cytometer. All samples were collected with identical voltage parameters. Acquired data were analyzed using the FlowJo software. The gating strategy included: (a) gating on yeast cells on forward versus side scatter plots; (b) gating on single cells using forward scatter width versus forward scatter height plots and (c) selecting positive cells based on histograms from wild-type cells. Three biological replicates were tested for each analyzed clone and the mean of the three values is presented.

Data analysis

Statistical analyses and figures were made on GraphPad Prims 5 software. ANOVA followed by Tukey’s post-test was applied. Error bars on graphics represent standard error of the mean.


Authors’ contributions

MB carried out the experimental studies and drafted the manuscript. VR and JLDM participated in the design of the study and helped to draft the manuscript. AMN performed and analyzed the flow cytometry experiments. LM participated in the design of the study. FT conceived the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.


The authors wish to thank CNPq (Grant # 441978/2014-2) and FAPDF (Grant # 193.000.582/2009) for financial support of this Project.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

All data and material concerning supporting the conclusions of this work is presented in the main paper and is made public available.

Consent for publication

We consent BioMed Central to publish this manuscript should it be accepted for so.


CNPq (Grant # 441978/2014-2), FAPDF (Grant # 193.000.582/2009).

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Authors’ Affiliations

Laboratório de Biologia Molecular, Departamento de Biologia Celular, Instituto de Ciências Biológicas, Universidade de Brasília
Faculdade de Medicina, Laboratório de Imunologia Celular, Universidade de Brasília


  1. Gasser B, Prielhofer R, Marx H, Maurer M, Nocon J, Steiger M, Puxbaum V, Sauer M, Mattanovich D. Pichia pastoris: protein production host and model organism for biomedical research. Future Microbiol. 2013;8:191–208.View ArticleGoogle Scholar
  2. Ahmad M, Hirz M, Pichler H, Schwab H. Protein expression in Pichia pastoris: recent achievements and perspectives for heterologous protein production. Appl Microbiol Biotechnol. 2014;98:5301–17.View ArticleGoogle Scholar
  3. Heyland J, Fu J, Blank LM, Schmid A. Quantitative physiology of Pichia pastoris during glucose-limited high-cell density fed-batch cultivation for recombinant protein production. Biotechnol Bioeng. 2010;107:357–68.View ArticleGoogle Scholar
  4. Mellitzer A, Ruth C, Gustafsson C, Welch M, Birner-Grünberger R, Weis R, Purkarthofer T, Glieder A. Synergistic modular promoter and gene optimization to push cellulase secretion by Pichia pastoris beyond existing benchmarks. J Biotechnol. 2014;191:187–95.View ArticleGoogle Scholar
  5. Lin Cereghino GP, Lin Cereghino J, Ilgen C, Cregg JM. Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr Opin Biotechnol. 2002;13:329–32.View ArticleGoogle Scholar
  6. Aw R, Polizzi KM. Can too many copies spoil the broth? Microb Cell Fact. 2013;12:128–36.View ArticleGoogle Scholar
  7. Piva LC, Betancur MO, Reis VCB, De Marco JL, Moraes LMP, Torres FAG. Molecular strategies to increase the levels of heterologous transcripts in Komagataella phaffii for protein production. Bioengineered 2017;1–5. doi:10.1080/21655979.2017.1296613.
  8. Sreekrishna K, Kropp KE. Pichia pastoris. In: Wolf K, editor. Nonconventional yeasts in biotechnology. Berlin: Springer; 1996. p. 203–53.View ArticleGoogle Scholar
  9. Wriessnegger T, Augustin P, Engleder M, Leitner E, Müller M, Kaluzna I, Schürmann M, Mink D, Zellnig G, Schwab H, Pichler H. Production of the sesquiterpenoid (+)-nootkatone by metabolic engineering of Pichia pastoris. Metab Eng. 2014;24:18–29.View ArticleGoogle Scholar
  10. Romanos M, Scorer C, Sreekrishna K, Clare J. The generation of multicopy recombinant strains. Methods Mol Biol. 1998;103:55–72.Google Scholar
  11. Lin-Cereghino J, Hashimoto MD, Moy A, Castelo J, Orazem CC, Kuo P, Xiong S, Gandhi V, Hatae CT, Chan A, Lin-Cereghino GP. Direct selection of Pichia pastoris expression strains using new G418 resistance vectors. Yeast. 2008;25:293–9.View ArticleGoogle Scholar
  12. Chen H-L, Yen C-C, Tsai T-C, Yu C-H, Liou Y-J, Lai Y-W, Wang M-L, Chen C-M. Production and characterization of human extracellular superoxide dismutase in the methylotrophic yeast Pichia pastoris. J Agric Food Chem. 2006;54:8041–7.View ArticleGoogle Scholar
  13. Sunga AJ, Tolstorukov I, Cregg JM. Posttransformational vector amplification in the yeast Pichia pastoris. FEMS Yeast Res. 2008;8:870–6.View ArticleGoogle Scholar
  14. Aw R, Polizzi KM. Liquid PTVA: a faster and cheaper alternative for generating multi-copy clones in Pichia pastoris. Microb Cell Fact. 2016;15:29–39.View ArticleGoogle Scholar
  15. Marx H, Mecklenbräuker A, Gasser B, Sauer M, Mattanovich D. Directed gene copy number amplification in Pichia pastoris by vector integration into the ribosomal DNA locus. FEMS Yeast Res. 2009;9:1260–70.View ArticleGoogle Scholar
  16. Kazemi Seresht A, Nørgaard P, Palmqvist EA, Andersen AS, Olsson L. Modulating heterologous protein production in yeast: the applicability of truncated auxotrophic markers. Appl Microbiol Biotechnol. 2013;97:3939–48.View ArticleGoogle Scholar
  17. Erhart E, Hollenberg CP. The presence of a defective LEU2 gene on 2 mu DNA recombinant plasmids of Saccharomyces cerevisiae is responsible for curing and high copy number. J Bacteriol. 1983;156:625–35.Google Scholar
  18. Hoylaerts M, Weyens A, Bollen A, Harford N, Cabezón T. High-level production and isolation of human recombinant alpha 1-proteinase inhibitor in yeast. FEBS Lett. 1986;204:83–7.View ArticleGoogle Scholar
  19. Servienë E, Melvydas V. Effect of the defective leucine gene leu2-d, on the properties of recombinant plasmid in yeast Saccharomyces cerevisiae. Biologija. 2001;4:30–3.Google Scholar
  20. Ro D-K, Ouellet M, Paradise EM, Burd H, Eng D, Paddon CJ, Newman JD, Keasling JD. Induction of multiple pleiotropic drug resistance genes in yeast engineered to produce an increased level of anti-malarial drug precursor, artemisinic acid. BMC Biotechnol. 2008;8:83–96.View ArticleGoogle Scholar
  21. Lin Cereghino GP, Lin Cereghino J, Sunga AJ, Johnson MA, Lim M, Gleeson MA, Cregg JM. New selectable marker/auxotrophic host strain combinations for molecular genetic manipulation of Pichia pastoris. Gene. 2001;263:159–69.View ArticleGoogle Scholar
  22. Nett JH, Gerngross TU. Cloning and disruption of the PpURA5 gene and construction of a set of integration vectors for the stable genetic modification of Pichia pastoris. Yeast. 2003;20:1279–90.View ArticleGoogle Scholar
  23. Nett JH, Hodel N, Rausch S, Wildt S. Cloning and disruption of the Pichia pastoris ARG1, ARG2, ARG3, HIS1, HIS2, HIS5, HIS6 genes and their use as auxotrophic markers. Yeast. 2005;22:295–304.View ArticleGoogle Scholar
  24. Weninger A, Hatzl AM, Schmid C, Vogl T, Glieder A. Combinatorial optimization of CRISPR/Cas9 expression enables precision genome engineering in the methylotrophic yeast Pichia pastoris. J Biotechnol. 2016;235:139–49.View ArticleGoogle Scholar
  25. Bussey H, Umbarger HE. Biosynthesis of the branched-chain amino acids in yeast: a leucine-binding component and regulation of leucine uptake. J Bacteriol. 1970;103:277–85.Google Scholar
  26. Wiame J, Grenson M, Arst HJ. Nitrogen catabolite repression in yeasts and filamentous fungi. Adv Microb Physiol. 1985;26:1–88.View ArticleGoogle Scholar
  27. Schreve J, Garrett JM. The branched-chain amino acid permease gene of Saccharomyces cerevisiae, BAP2, encodes the high-affinity leucine permease (S1). Yeast. 1997;13:435–9.View ArticleGoogle Scholar
  28. Grenson M, Hou C, Crabeel M. Multiplicity of the amino acid permeases in Saccharomyces cerevisiae. J Bacteriol. 1970;103:770–7.Google Scholar
  29. Jauniaux J, Grenson M. GAP1, the general amino acid permease gene of Saccharomyces cerevisiae. Nucleotide sequence, protein similarity with the other bakers yeast amino acid permeases, and nitrogen catabolite repression. Eur J Biochem. 1990;190:39–44.View ArticleGoogle Scholar
  30. Kotliar N, Stella C, Ramos E, Mattoon J. l-leucine transport systems in Saccharomyces cerevisiae participation of GAP1, S1 and S2 transport systems. Cell Mol Biol (Noisy-le-grand). 1994;40:833–42.Google Scholar
  31. Schreve JL, Garrett JM. Yeast Agp2p and Agp3p function as amino acid permeases in poor nutrient conditions. Biochem Biophys Res Commun. 2004;313:745–51.View ArticleGoogle Scholar
  32. Hueso G, Aparicio-Sanchis R, Montesinos C, Lorenz S, Murguía JR, Serrano R. A novel role for protein kinase Gcn2 in yeast tolerance to intracellular acid stress. Biochem J. 2012;441:255–64.View ArticleGoogle Scholar
  33. Horák J. Yeast nutrient transporters. Biochim Biophys Acta. 1997;1331:41–79.View ArticleGoogle Scholar
  34. Plant PJ, Manolson MF, Grinstein S, Demaurex N. Alternative mechanisms of vacuolar acidification in H+-ATPase-deficient yeast. J Biol Chem. 1999;274:37270–9.View ArticleGoogle Scholar
  35. Du M, Battles MB, Nett JH. A color-based stable multi-copy integrant selection system for Pichia pastoris using the attenuated ADE1 and ADE2 genes as auxotrophic markers. Bioeng Bugs. 2012;3:32–7.Google Scholar
  36. Schwarzhans J-P, Wibberg D, Winkler A, Luttermann T, Kalinowski J, Friehs K. Integration event induced changes in recombinant protein productivity in Pichia pastoris discovered by whole genome sequencing and derived vector optimization. Microb Cell Fact. 2016;15:84.View ArticleGoogle Scholar
  37. Näätsaari L, Mistlberger B, Ruth C, Hajek T, Hartner FS, Glieder A. Deletion of the Pichia pastoris KU70 homologue facilitates platform strain generation for gene expression and synthetic biology. PLoS ONE. 2012;7:e39720.View ArticleGoogle Scholar
  38. Ohi H, Okazaki N, Uno S, Miura M, Hiramatsu R. Chromosomal DNA patterns and gene stability of Pichia pastoris. Yeast. 1998;14:895–903.View ArticleGoogle Scholar
  39. Lim H-K, Kim K-Y, Lee K-J, Park D-H, Chung S-I, Jung K-H. Genetic stability of the integrated structural gene of guamerin in recombinant Pichia pastoris. J Microbiol Biotechnol. 2000;10:470–5.Google Scholar
  40. Lee FW, Da Silva NA. Improved efficiency and stability of multiple cloned gene insertions at the delta sequences of Saccharomyces cerevisiae. Appl Microbiol Biotechnol. 1997;48:339–45.View ArticleGoogle Scholar
  41. Moon HK, Lee DW, Sim GH, Kim H-J, Hwang JY, Kwon M-G, Kang B-K, Kim JM, Kang HA. A new set of rDNA-NTS-based multiple integrative cassettes for the development of antibiotic-marker-free recombinant yeasts. J Biotechnol. 2016;233:190–9.View ArticleGoogle Scholar
  42. Wang X, Wang Z, Da Silva NA. G418 selection and stability of cloned genes integrated at chromosomal delta sequences of Saccharomyces cerevisiae. Biotechnol Bioeng. 1996;49:45–51.View ArticleGoogle Scholar
  43. Zhu T, Guo M, Sun C, Qian J, Zhuang Y, Chu J, Zhang S. A systematical investigation on the genetic stability of multi-copy Pichia pastoris strains. Biotechnol Lett. 2009;31:679–84.View ArticleGoogle Scholar
  44. Stadlmayr G, Mecklenbräuker A, Rothmüller M, Maurer M, Sauer M, Mattanovich D, Gasser B. Identification and characterisation of novel Pichia pastoris promoters for heterologous protein production. J Biotechnol. 2010;150:519–29.View ArticleGoogle Scholar
  45. Vassileva A, Chugh D, Swaminathan S, Khanna N. Effect of copy number on the expression levels of hepatitis B surface antigen in the methylotrophic yeast Pichia pastoris. Protein Expr Purif. 2001;21:71–80.View ArticleGoogle Scholar
  46. Liu H, Qin Y, Huang Y, Chen Y, Cong P, He Z. Direct evaluation of the effect of gene dosage on secretion of protein from yeast Pichia pastoris by expressing EGFP. JMicrobiol Biotechnol. 2014;24:144–51.View ArticleGoogle Scholar
  47. Hohenblum H, Gasser B, Maurer M, Borth N, Mattanovich D. Effects of gene dosage, promoters, and substrates on unfolded protein stress of recombinant Pichia pastoris. Biotechnol Bioeng. 2004;85:367–75.View ArticleGoogle Scholar
  48. Sambrook J, Fritsch EF, Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbor Laboratory Press; 1989.Google Scholar
  49. Reis VCB, Nicola AM, de Souza Oliveira Neto O, Batista VDF, de Moraes LMP, Torres FAG. Genetic characterization and construction of an auxotrophic strain of Saccharomyces cerevisiae JP1, a Brazilian industrial yeast strain for bioethanol production. J Ind Microbiol Biotechnol. 2012;39:1673–83.View ArticleGoogle Scholar
  50. Arruda A, Reis VCB, Batista VDF, Daher BS, Piva LC, de Marco JL, de Moraes LMP, Torres FAG. A constitutive expression system for Pichia pastoris based on the PGK1 promoter. Biotechnol Lett. 2016;38:509–17.View ArticleGoogle Scholar
  51. Lueking A, Horn S, Lehrach H, Cahill D. A dual-expression vector allowing expression in E. coli and P. pastoris, including new modifications. In: Vaillancourt P, editor. E. coli gene expression protocols SE3, vol. 205. Totowa: Humana Press; 2003. p. 31–42 (Methods in Molecular Biology™).View ArticleGoogle Scholar


© The Author(s) 2017